{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T17:26:30Z","timestamp":1791307590666,"version":"4.3.1"},"reference-count":55,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2012,3,27]],"date-time":"2012-03-27T00:00:00Z","timestamp":1332806400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0032789","type":"journal-article","created":{"date-parts":[[2012,3,27]],"date-time":"2012-03-27T22:02:33Z","timestamp":1332885753000},"page":"e32789","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":36,"title":["The Naturally Occurring YMDD Mutation among Patients Chronically Infected HBV and Untreated with Lamivudine: A Systematic Review and Meta-Analysis"],"prefix":"10.1371","volume":"7","author":[{"given":"Youwen","family":"Tan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keqin","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Trinh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihang","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhua","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongbin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2012,3,27]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S1473-3099(02)00315-8","article-title":"Global control of hepatitis B virus infection.","volume":"2","author":"JH Kao","year":"2002","journal-title":"Lancet Infect Dis"},{"key":"ref2","first-page":"714","article-title":"Mutation in HBV RNA-dependent DNA polymerase confers resistance to lamivudine in vivo.","volume":"24","author":"GA Tipples","year":"1996","journal-title":"Hepatology"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1111\/j.1440-1746.2006.04768.x","article-title":"How do naturally occurring YMDD-motif mutants influence the clinical course of lamivudine-na\u00efve patients with chronic hepatitis B virus infection?","volume":"21","author":"A Tsubota","year":"2006","journal-title":"J Gastroenterol Hepatol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1002\/hep.510270628","article-title":"Identification and characterization of mutations in hepatitis B virus resistant to lamivudine.","volume":"27","author":"MI Allen","year":"1998","journal-title":"Hepatology"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1053\/jhep.2001.22166","article-title":"Nomenclature for antiviral-resistant human hepatitis B virus mutations in the polymerase region.","volume":"33","author":"LJ Stuyver","year":"2001","journal-title":"Hepatology"},{"key":"ref6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement.","volume":"6","author":"D Moher","year":"2009","journal-title":"Plos Medicine"},{"key":"ref7","first-page":"47","article-title":"The detection of YMDD mutation in CHB patients in Enshi Autonomous Prefecture.","volume":"27","author":"T Xiang","year":"2010","journal-title":"Journal of Hubei University for Nationalities"},{"key":"ref8","first-page":"855","article-title":"Experimental research for YMDD motif natural mutations in the serum of patients with chronic hepatitis B.","volume":"18","author":"J Wei","year":"2010","journal-title":"Chinese Journal of Hepatology"},{"key":"ref9","first-page":"1544","article-title":"Detection of spontaneous hepatitis B virus YMDD motif mutation by fluorescent hybridization double-probe PCR and melting curve assay.","volume":"19","author":"XL Tang","year":"2009","journal-title":"Chinese Journal of Modern Medicine"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.cca.2006.05.023","article-title":"Rapid quantitation of lamivudine-resistant mutants in lamivudine treated and untreated patients with chronic hepatitis B virus infection.","volume":"373","author":"M Shi","year":"2006","journal-title":"Clin Chim Acta"},{"key":"ref11","first-page":"42","article-title":"Study on the therapeutic efficacy of lamivudine in chronic hepatitis B patients with YMDD mutations.","volume":"45","author":"QS Qi","year":"2005","journal-title":"Acta Academiae Medicine Jiangxi"},{"key":"ref12","first-page":"421","article-title":"Detection of YMDD mutants in patients with chronic hepatitis B during lamivudine treatment.","volume":"6","author":"Y Xiong","year":"2005","journal-title":"Journal of Beihua University"},{"key":"ref13","first-page":"83","article-title":"Detection of YMDD mutation in CHB patients untreated with antiviral medicine.","volume":"7","author":"YQ Ren","year":"2004","journal-title":"Journal of Clinical Hepatology"},{"key":"ref14","first-page":"46","article-title":"Detection and analysis of HBV YMDD-motif mutants before and during lamivudine treatment.","volume":"18","author":"C Wu","year":"2007","journal-title":"Medical Laboratory Science and Clinics"},{"key":"ref15","first-page":"405","article-title":"Detection of hepatitis B virus YMDD mutants and its clinical significance in patients with chronic hepatitis B.","volume":"3","author":"JF Wang","year":"2003","journal-title":"World Journal of infection"},{"key":"ref16","first-page":"887","article-title":"The spontaneous YMDD mutation rate in chronic hepatitis B patients.","volume":"17","author":"XC Min","year":"2009","journal-title":"Chinese Journal of Hepatology"},{"key":"ref17","first-page":"232","article-title":"Epidemiological survey of spontaneous HBV YMDD motif mutation.","volume":"11","author":"H Huo","year":"2006","journal-title":"Chinese Hepatology"},{"key":"ref18","first-page":"19","article-title":"Detection of YMDD mutation in patients with hepatitis B by double probe FQ-PCR assay.","volume":"1","author":"HZ Yu","year":"2009","journal-title":"Medical Information"},{"key":"ref19","first-page":"408","article-title":"Detection of YMDD motif mutation in lamivudine-treated and untreated CHB patients.","volume":"28","author":"JB Qian","year":"2002","journal-title":"Journal of Jiangsu Medicine"},{"key":"ref20","first-page":"350","article-title":"Study of the disease progress and clinical treatment in the hepatitis B patients with YMDD mutation.","volume":"23","author":"YW Qiu","year":"2008","journal-title":"Clinical Focus"},{"key":"ref21","first-page":"1123","article-title":"Relationship of YMDD mutations and genotypes of HBV in antivirus-untreated patients with chronic hepatitis B.","volume":"2","author":"NL Chen","year":"2008","journal-title":"Chinese Journal of Clinical Physician"},{"key":"ref22","first-page":"22","article-title":"Clinical analysis on YMDD-motif spontaneous mutation in patients with chronic hepatitis B.","volume":"44","author":"JM Zhang","year":"2004","journal-title":"Journal of Shangdong Medicine"},{"key":"ref23","first-page":"261","article-title":"Detection of YMDD mutation in HBV polymerase gene region with nested PCR.","volume":"18","author":"JM Zheng","year":"2003","journal-title":"Shanghai Journal of Medical Laboratorial Science"},{"key":"ref24","first-page":"11","article-title":"Analysis of YMDD mutation in antiviral-untreated patients with chronic hepatitis B.","volume":"18","author":"FJ Cheng","year":"2006","journal-title":"Zhejiang Journal of Preventive Medicine"},{"key":"ref25","first-page":"213","article-title":"Detection of naturally emerging HBV YMDD mutation.","volume":"23","author":"NH Zheng","year":"2007","journal-title":"Chinese Journal of Clinical Hepatology"},{"key":"ref26","first-page":"430","article-title":"Detection of YMDD motif mutation in lamivudine-untreated patients with chronic hepatitis B.","volume":"11","author":"MH Yan","year":"2003","journal-title":"Chinese Journal of Hepatology"},{"key":"ref27","first-page":"714","article-title":"Correlation between hepatitis B virus genotypes and natural mutation of YMDD in Hainan.","volume":"15","author":"J Wu","year":"2009","journal-title":"Journal of Hainan Medical College"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"867","DOI":"10.3748\/wjg.v11.i6.867","article-title":"YMDD mutations in patients with chronic hepatitis B untreated with antiviral medicines.","volume":"11","author":"ZM Huang","year":"2005","journal-title":"World J Gastroenterol"},{"key":"ref29","first-page":"1551","article-title":"The study of natural HBV YMDD mutation in 125 Zhuang patients with chronic hepatitis in Guangxi province.","volume":"7","author":"YQ Qian","year":"2005","journal-title":"Journal of Chinese Physician"},{"key":"ref30","first-page":"791","article-title":"Clinical analysis of HBV YMDD mutation in patients untreated with lamivudine.","volume":"6","author":"YY Qu","year":"2006","journal-title":"Journal of Tropical Medicine"},{"key":"ref31","first-page":"1483","article-title":"Study on the relationship between lamivudine treatment and YMDD motif mutation.","volume":"8","author":"JH Liu","year":"2008","journal-title":"Journal of Chinese Tropical Medicine"},{"key":"ref32","first-page":"107","article-title":"HBV genotyping and detecting of YMDD mutation in patients chronically infected HBV and untreated with antiviral drugs.","volume":"24","author":"HB Guo","year":"2004","journal-title":"Journal of Chinese Biotechnology"},{"key":"ref33","first-page":"63","article-title":"Detection of HBV gene mutation and analyzing for the correlation factors of the mutations.","volume":"13","author":"J Yu","year":"2007","journal-title":"International Medicine and Health Guidance News"},{"key":"ref34","first-page":"137","article-title":"Detection of lamivudine-resistant HBV YMDD mutation and analyzing the relative factors of YMDD mutation.","volume":"13","author":"CM Li","year":"2003","journal-title":"Chinese Journal of Integrated Traditional and Western Medicine on Liver Diseases"},{"key":"ref35","first-page":"459","article-title":"The study of gene chips in detecting YMDD mutations in the region of HBV polymerase.","volume":"83","author":"XH Zhang","year":"2003","journal-title":"National Medical Journal of China"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.11569\/wcjd.v18.i24.2604","article-title":"Spontaneous HBV YMDD motif mutations in patients with familial clustered chronic HBV infection.","volume":"18","author":"JX Qu","year":"2010","journal-title":"World Chinese Journal of Digestology"},{"key":"ref37","first-page":"116","article-title":"Study in naturally occurring HBV YMDD mutations in patients with hepatic cirrhosis.","volume":"24","author":"JX Qu","year":"2008","journal-title":"Chinese Journal of Clinical Hepatology"},{"key":"ref38","first-page":"2094","article-title":"Epidemiological survey for spontaneous HBV YMDD motif mutation of CHB patients whom under 20 years old and in immune tolerant phase.","volume":"23","author":"HQ Pan","year":"2010","journal-title":"Medical Information"},{"key":"ref39","first-page":"13","article-title":"The study of natural HBV YMDD-motif mutation in patients with chronic hepatitis B.","volume":"19","author":"Y Zhang","year":"2005","journal-title":"Military Medical Journal of South China"},{"key":"ref40","first-page":"167","article-title":"Detection of HBV YMDD mutation in patients with chronic hepatitis B and its significance.","volume":"27","author":"L Li","year":"2005","journal-title":"Acta Academiae Medicinae Militaris Tertiae"},{"key":"ref41","first-page":"29","article-title":"Detection of YMDD mutation in patients with chronic hepatitis B after lamivudine treatment.","volume":"13","author":"TH Liu","year":"2004","journal-title":"Chinese Pharmaceuticals"},{"key":"ref42","first-page":"895","article-title":"Analysis on the HBV polymerase gene mutation in lamivudine-resistant patients.","volume":"38","author":"X He","year":"2007","journal-title":"Journal of Sichuan University"},{"key":"ref43","first-page":"652","article-title":"Clinical analysis of natural mutation of YMDD in HBV infection patients.","volume":"9","author":"YQ Wang","year":"2009","journal-title":"Journal of China Tropical Medicine"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/jmv.20185","article-title":"YMDD mutants in patients with chronic hepatitis B before treatment are not selected by lamivudine.","volume":"74","author":"M Matsuda","year":"2004","journal-title":"J Med Virol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/(SICI)1096-9071(200001)60:1<8::AID-JMV2>3.0.CO;2-U","article-title":"Emergence of YMDD motif mutants of hepatitis B virus during lamivudine treatment of immunocompetent type B hepatitis patients.","volume":"60","author":"T Seta","year":"2000","journal-title":"J Med Virol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/S0168-8278(00)00023-4","article-title":"Detection of YMDD motif mutations in some lamivudine-untreated asymptomatic hepatitis B virus carriers.","volume":"34","author":"S Kobayashi","year":"2001","journal-title":"J Hepatol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"541","DOI":"10.3346\/jkms.2004.19.4.541","article-title":"Detection of YMDD motif mutants by oligonucleotide chips in lamivudine-untreated patients with chronic hepatitis B virus infection.","volume":"19","author":"J Heo","year":"2004","journal-title":"J Korean Med Sci"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ijid.2007.05.001","article-title":"Hepatitis B virus (HBV) genotype and YMDD motif mutation profile among patients infected with HBV and untreated with lamivudine.","volume":"12","author":"S Amini-Bavil-Olyaee","year":"2008","journal-title":"Int J Infec Dis"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.ijid.2007.08.003","article-title":"Rate of YMDD motif mutants in lamivudine-untreated Iranian patients with chronic hepatitis B virus infection.","volume":"12","author":"A Ramezani","year":"2008","journal-title":"Int J Infec Dis"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.3851\/IMP1465","article-title":"Pretreatment with pegylated interferon prevents emergence of lamivudine mutants in lamivudine-naive patients: a pilot study.","volume":"14","author":"E Villa","year":"2009","journal-title":"Antivir Ther"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1111\/j.1440-1746.2006.04567.x","article-title":"Detection of YMDD motif variants in inactive hepatitis B carriers by Inno-Lipa HBV DR assay.","volume":"21","author":"M Akarsu","year":"2006","journal-title":"J Gastroenterol and Hepatol"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"7231","DOI":"10.3748\/wjg.14.7231","article-title":"Hepatitis B virus genotypes and lamivudine resistance mutations in Jordan.","volume":"14","author":"HA Masaadeh","year":"2008","journal-title":"World J Gastroenterol"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1002\/jmv.20974","article-title":"Mutations associated with lamivudine-resistance in therapy-naive hepatitis B virus (HBV) infected patients with and without HIV co-infection: implications for antiretroviral therapy in HBV and HIV co-Infected South African patients.","volume":"79","author":"SG Selabe","year":"2007","journal-title":"J Med Virol"},{"key":"ref54","first-page":"319A","article-title":"Clinical significance of YMDD mutant hepatitis B virus (HBV) in a large cohort of lamivudine-treated hepatitis B patients.","volume":"28","author":"M Atkins","year":"1998","journal-title":"Hepatology"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1159\/000080872","article-title":"Genetic diversity of hepatitis B virus strains derived worldwide: genotypes, subgenotypes, and HBsAg subtypes.","volume":"47","author":"H Norder","year":"2004","journal-title":"Intervirology"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0032789","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,19]],"date-time":"2018-10-19T23:49:32Z","timestamp":1539992972000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0032789"}},"subtitle":[],"editor":[{"given":"Joerg F.","family":"Schlaak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2012,3,27]]},"references-count":55,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2012,3,27]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0032789","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,27]]}}}